2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

[1]  David M. Reboussin,et al.  Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2018, Hypertension.

[2]  James R. Powell,et al.  Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial , 2017, Diabetes Care.

[3]  Pavel S. Roshanov,et al.  Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort , 2017, Anesthesiology.

[4]  P. Whelton,et al.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis , 2017, JAMA cardiology.

[5]  S. Bangalore,et al.  Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. , 2017, The American journal of medicine.

[6]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[7]  J. Rehm,et al.  The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. , 2017, The Lancet. Public health.

[8]  Ivy Shiue,et al.  Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015 , 2017, JAMA.

[9]  L. Fleisher,et al.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease , 2016, Circulation.

[10]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.

[11]  A. Alexandrov,et al.  Blood Pressure Reduction and Secondary Stroke Prevention: A Systematic Review and Metaregression Analysis of Randomized Clinical Trials , 2017, Hypertension.

[12]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Circulation.

[13]  M. Walsh,et al.  Women, Hypertension, and the Systolic Blood Pressure Intervention Trial. , 2016, The American journal of medicine.

[14]  G. Reboldi,et al.  More Versus Less Intensive Blood Pressure–Lowering StrategyNovelty and Significance , 2016 .

[15]  N. Cook,et al.  Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. , 2016, Hypertension.

[16]  Rui Chen,et al.  CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. , 2016, The New England journal of medicine.

[17]  Lenore J Launer,et al.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. , 2016, JAMA.

[18]  D. Hanley,et al.  Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. , 2016, The New England journal of medicine.

[19]  J. Cigarroa,et al.  Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Circulation.

[20]  S. Yusuf,et al.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[21]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials , 2016, Journal of hypertension.

[22]  C. Chiang,et al.  Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke , 2016, Medicine.

[23]  S. Anderson,et al.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[24]  W. Young,et al.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[25]  N. Smart,et al.  Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit , 2016, Hypertension Research.

[26]  M. Woodward,et al.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.

[27]  A. Murray,et al.  Comparison of stethoscope bell and diaphragm, and of stethoscope tube length, for clinical blood pressure measurement , 2016, Blood pressure monitoring.

[28]  A. Rodgers,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[29]  Standards of Medical Care in Diabetes—2016: Summary of Revisions , 2015, Diabetes Care.

[30]  D. Goff,et al.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial. , 2015, Hypertension.

[31]  A. Siu.  Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. , 2015, Annals of internal medicine.

[32]  Di Zhao,et al.  Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: a meta-analysis of randomized controlled trials , 2015, Journal of biomedical research.

[33]  B. Spring,et al.  Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. , 2015, Circulation.

[34]  Alan B Leichtman,et al.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  Rong Zhao,et al.  Blood Pressure Reduction in the Acute Phase of an Ischemic Stroke Does Not Improve Short- or Long-Term Dependency or Mortality , 2015, Medicine.

[36]  M. Tonelli,et al.  Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis , 2015, The Lancet.

[37]  Jane A. Linderbaum,et al.  2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of Advanced Practice Providers. , 2015, Journal of the American College of Cardiology.

[38]  Christopher M O'Connor,et al.  Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension , 2015, Hypertension.

[39]  E. Reisin,et al.  Anti-hypertensive Drug Treatment of Patients with and the Metabolic Syndrome and Obesity: a Review of Evidence, Meta-Analysis, Post hoc and Guidelines Publications , 2015, Current Hypertension Reports.

[40]  E. Muxfeldt,et al.  Effects of Continuous Positive Airway Pressure Treatment on Clinic and Ambulatory Blood Pressures in Patients With Obstructive Sleep Apnea and Resistant Hypertension: A Randomized Controlled Trial , 2015, Hypertension.

[41]  T. Vaughn,et al.  Cluster-Randomized Trial of a Physician/Pharmacist Collaborative Model to Improve Blood Pressure Control , 2015, Circulation. Cardiovascular quality and outcomes.

[42]  B. Prendergast,et al.  A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial) , 2015, European heart journal cardiovascular Imaging.

[43]  G. Lipkin,et al.  Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits , 2015, Expert review of clinical pharmacology.

[44]  K. Rahimi,et al.  Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.

[45]  A. Turchin,et al.  Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study , 2015, BMJ : British Medical Journal.

[46]  M. Woodward,et al.  Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. , 2015, Annals of internal medicine.

[47]  Evelyn P Whitlock,et al.  Diagnostic and Predictive Accuracy of Blood Pressure Screening Methods With Consideration of Rescreening Intervals: A Systematic Review for the U.S. Preventive Services Task Force , 2015, Annals of Internal Medicine.

[48]  E. Reisin,et al.  Treatment: special conditions. Metabolic syndrome: obesity and the hypertension connection. , 2015, Journal of the American Society of Hypertension : JASH.

[49]  Dingli Xu,et al.  Prehypertension and the Risk of Coronary Heart Disease in Asian and Western Populations: A Meta‐analysis , 2015, Journal of the American Heart Association.

[50]  Akshay S. Desai,et al.  Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial , 2015, Circulation.

[51]  M. Woodward,et al.  Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes MellitusNovelty and Significance , 2015 .

[52]  M. Weir.  In the clinic: hypertension. , 2014, Annals of internal medicine.

[53]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[54]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels – overview and meta-analyses of randomized trials , 2014, Journal of hypertension.

[55]  J. Rumsfeld,et al.  Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. , 2014, Journal of the American College of Cardiology.

[56]  E. O’Brien,et al.  Setting Thresholds to Varying Blood Pressure Monitoring Intervals Differentially Affects Risk Estimates Associated With White-Coat and Masked Hypertension in the Population , 2014, Hypertension.

[57]  Kevin L. Thomas,et al.  Check It, Change It: A Community-Based, Multifaceted Intervention to Improve Blood Pressure Control , 2014, Circulation. Cardiovascular quality and outcomes.

[58]  E. Laws,et al.  Acromegaly: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[59]  Richard A. Goodman,et al.  AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services. , 2014, Circulation.

[60]  R. Eckel,et al.  Pharmacological treatment and therapeutic perspectives of metabolic syndrome , 2014, Reviews in Endocrine and Metabolic Disorders.

[61]  J. Bilal,et al.  Meta-analysis of revascularization versus medical therapy for atherosclerotic renal artery stenosis. , 2014, The American journal of cardiology.

[62]  S. Laurent,et al.  Dose-Dependent Arterial Destiffening and Inward Remodeling After Olmesartan in Hypertensives With Metabolic Syndrome , 2014, HYPERTENSION.

[63]  Jeffrey L. Anderson,et al.  The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[64]  R. Sacco,et al.  Population Attributable Risks of Hypertension and Diabetes for Cardiovascular Disease and Stroke in the Northern Manhattan Study , 2014, Journal of the American Heart Association.

[65]  Andrew W. Correia,et al.  Temporal Trends in the Population Attributable Risk for Cardiovascular Disease: The Atherosclerosis Risk in Communities Study , 2014, Circulation.

[66]  P. Dong,et al.  Brachial Pulse Pressure and Cardiovascular or All‐Cause Mortality in the General Population: A Meta‐Analysis of Prospective Observational Studies , 2014, Journal of clinical hypertension.

[67]  Emma P Bray,et al.  Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. , 2014, JAMA.

[68]  M. Woodward,et al.  Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data , 2014, The Lancet.

[69]  Majid Ezzati,et al.  Global sodium consumption and death from cardiovascular causes. , 2014, The New England journal of medicine.

[70]  Laura A. Tuttle,et al.  Reproducibility of masked hypertension among adults 30 years or older , 2014, Blood pressure monitoring.

[71]  P. Levy,et al.  Impact of initial blood pressure on antihypertensive response in patients with acute hypertension. , 2014, The American journal of emergency medicine.

[72]  David W. Baker,et al.  A Technology-Based Quality Innovation to Identify Undiagnosed Hypertension Among Active Primary Care Patients , 2014, The Annals of Family Medicine.

[73]  Anilkrishna B. Thota,et al.  Team-based care and improved blood pressure control: a community guide systematic review. , 2014, American journal of preventive medicine.

[74]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[75]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[76]  Xiao-peng Hu,et al.  Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta‐analysis , 2014, Chinese medical journal.

[77]  Walter T Ambrosius,et al.  The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) , 2014, Clinical trials.

[78]  G. Fonarow,et al.  ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Circulation.

[79]  W. Young,et al.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[80]  Harry Hemingway,et al.  Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people , 2014, The Lancet.

[81]  Ying Peng,et al.  Effects of Early Blood Pressure Lowering on Early and Long-Term Outcomes after Acute Stroke: An Updated Meta-Analysis , 2014, PloS one.

[82]  S. Daniels,et al.  Update: Ambulatory Blood Pressure Monitoring in Children and Adolescents A Scientific Statement From the American Heart Association , 2014, Hypertension.

[83]  J. Staessen,et al.  Prognosis of White-Coat and Masked Hypertension: International Database of Home Blood Pressure in Relation to Cardiovascular Outcome , 2014, Hypertension.

[84]  Yuli Huang,et al.  Prehypertension and the risk of stroke , 2014, Neurology.

[85]  A. Mebazaa,et al.  Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO). , 2014, American heart journal.

[86]  Willie Lawrence,et al.  An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention , 2013, Hypertension.

[87]  M. Burnier,et al.  Improving Blood Pressure Control Through Pharmacist Interventions: A Meta‐Analysis of Randomized Controlled Trials , 2014, Journal of the American Heart Association.

[88]  C. Horikawa,et al.  Meta-analysis of the quantitative relation between pulse pressure and mean arterial pressure and cardiovascular risk in patients with diabetes mellitus. , 2014, The American journal of cardiology.

[89]  J. Cutler,et al.  Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial , 2014, Diabetes Care.

[90]  N. Smart,et al.  Isometric exercise training for blood pressure management: a systematic review and meta-analysis. , 2014, Mayo Clinic proceedings.

[91]  L. Køber,et al.  Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. , 2014, JAMA internal medicine.

[92]  Ralph B D'Agostino,et al.  Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.

[93]  Yoshitaka 義孝 Murakami 村上.  Meta-analyses Using Individual Participant Data From Cardiovascular Cohort Studies in Japan: Current Status and Future Directions , 2014, Journal of epidemiology.

[94]  J. Chen,et al.  Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. , 2014, JAMA.

[95]  P. Whelton,et al.  Health effects of sodium and potassium in humans , 2014, Current opinion in lipidology.

[96]  Dingli Xu,et al.  Association of all-cause and cardiovascular mortality with prehypertension: a meta-analysis. , 2014, American heart journal.

[97]  P. Glasziou,et al.  General practitioners’ use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study , 2013, BMJ Open.

[98]  R. Shaw,et al.  Effects of Nurse-Managed Protocols in the Outpatient Management of Adults With Chronic Conditions , 2014, Annals of Internal Medicine.

[99]  Jianyu Zhang,et al.  Prehypertension and Incidence of ESRD: a systematic review and meta-analysis. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[100]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[101]  M. Mosteiro,et al.  Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. , 2013, JAMA.

[102]  Z. Li,et al.  Association Between Pre-hypertension and Cardiovascular Outcomes: A Systematic Review and Meta-analysis of Prospective Studies , 2013, Current Hypertension Reports.

[103]  P. Peduzzi,et al.  Combined angiotensin inhibition for the treatment of diabetic nephropathy. , 2013, The New England journal of medicine.

[104]  D. de Zeeuw,et al.  Screening for albuminuria with subsequent screening for hypertension and hypercholesterolaemia identifies subjects in whom treatment is warranted to prevent cardiovascular events. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[105]  L. Bortolotto,et al.  Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. , 2013, Chest.

[106]  J. Saavedra,et al.  Effects of exercise on resting blood pressure in obese children: a meta‐analysis of randomized controlled trials , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[107]  José Agustín Arguedas,et al.  Blood pressure targets for hypertension in people with diabetes mellitus. , 2013, The Cochrane database of systematic reviews.

[108]  Juan Xu,et al.  Impact of baseline prehypertension on cardiovascular events and all-cause mortality in the general population: a meta-analysis of prospective cohort studies. , 2013, International journal of cardiology.

[109]  M. Lauer,et al.  Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. , 2013, Circulation.

[110]  M. Woodward,et al.  Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials , 2013, BMJ.

[111]  R. Nishimura,et al.  Systemic Hypertension in Low-Gradient Severe Aortic Stenosis With Preserved Ejection Fraction , 2013, Circulation.

[112]  T. Urech,et al.  Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial. , 2013, JAMA.

[113]  Mark Woodward,et al.  Comparison of the Sex-Specific Associations Between Systolic Blood Pressure and the Risk of Cardiovascular Disease: A Systematic Review and Meta-analysis of 124 Cohort Studies, Including 1.2 Million Individuals , 2013, Stroke.

[114]  Geoffrey A Head,et al.  European Society of Hypertension position paper on ambulatory blood pressure monitoring. , 2013, Journal of hypertension.

[115]  A. Go,et al.  Improved Blood Pressure Control Associated with a Large-scale Hypertension Program Downloaded From: Http://jama.jamanetwork.com/ by Edgardo Sandoya on 08/28/2013 , 2022 .

[116]  R. Conwit,et al.  Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial , 2013, The Lancet.

[117]  H. Tighiouart,et al.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.

[118]  Dingli Xu,et al.  Prehypertension and incidence of cardiovascular disease: a meta-analysis , 2013, BMC Medicine.

[119]  P. Stevens,et al.  The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[120]  K. Costenbader,et al.  The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. , 2013, Seminars in arthritis and rheumatism.

[121]  Mei-xiang Xiang,et al.  Meta-analysis of cohort studies of baseline prehypertension and risk of coronary heart disease. , 2013, The American journal of cardiology.

[122]  Patrick J O'Connor,et al.  Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. , 2013, JAMA.

[123]  G. Mancia,et al.  Long-Term Prognostic Value of White Coat Hypertension: An Insight From Diagnostic Use of Both Ambulatory and Home Blood Pressure Measurements , 2013, Hypertension.

[124]  Pablo Perel,et al.  The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review , 2013, PLoS medicine.

[125]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[126]  C. Gluud,et al.  Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. , 2013, The Cochrane database of systematic reviews.

[127]  Gunther Eysenbach,et al.  Reducing blood pressure with Internet-based interventions: a meta-analysis. , 2013, The Canadian journal of cardiology.

[128]  K. Lavoie,et al.  The evolution of a Canadian Hypertension Education Program recommendation: the impact of resistance training on resting blood pressure in adults as an example. , 2013, The Canadian journal of cardiology.

[129]  Zhaoqing Sun,et al.  Prehypertension Is Not Associated with All-Cause Mortality: A Systematic Review and Meta-Analysis of Prospective Studies , 2013, PloS one.

[130]  W. Henderson,et al.  Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. , 2013, JAMA.

[131]  Lee Hooper,et al.  Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.

[132]  P. Elliott,et al.  Effect of lower sodium intake on health: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.

[133]  G. MacGregor,et al.  Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials , 2013, BMJ : British Medical Journal.

[134]  Tom Chan,et al.  Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results , 2013, Kidney international.

[135]  Gianfranco Parati,et al.  Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies , 2013, Journal of hypertension.

[136]  J. Buitelaar,et al.  Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. , 2013, Journal of child psychology and psychiatry, and allied disciplines.

[137]  E. Roccella,et al.  The Treatment of Hypertension: A Remarkable Success Story , 2013, Journal of clinical hypertension.

[138]  V. Cornelissen,et al.  Exercise Training for Blood Pressure: A Systematic Review and Meta‐analysis , 2013, Journal of the American Heart Association.

[139]  Harlan M Krumholz,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[140]  Deepak L. Bhatt,et al.  ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[141]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[142]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[143]  Helmut Baumgartner,et al.  The 2013 ESH/ESC guidelines for the management of arterial hypertension , 2013 .

[144]  B. Davis,et al.  The Glycemic Effects of Antihypertensive Medications , 2013, Current Hypertension Reports.

[145]  D. DeMets,et al.  Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. , 2013, Journal of the American Pharmacists Association : JAPhA.

[146]  Michael D. Jensen,et al.  Reprint: 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. , 2013, Journal of the American Pharmacists Association : JAPhA.

[147]  M. Jessup,et al.  The next steps in developing clinical practice guidelines for prevention. , 2013, Journal of the American College of Cardiology.

[148]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[149]  M. Yang,et al.  Immunosuppressant utilization and cardiovascular complications among Chinese patients after kidney transplantation: a systematic review and analysis , 2013, International Urology and Nephrology.

[150]  Audrey Y. Chu,et al.  Body Mass Index and Risk of Incident Hypertension Over the Life Course: The Johns Hopkins Precursors Study , 2012, Circulation.

[151]  Nish Chaturvedi,et al.  Cardiorenal end points in a trial of aliskiren for type 2 diabetes. , 2012, The New England journal of medicine.

[152]  T. Ohkubo,et al.  Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years , 2012, Journal of hypertension.

[153]  K. Pietz,et al.  Financial incentives and physician commitment to guideline-recommended hypertension management. , 2012, American Journal of Managed Care.

[154]  Jean Sanderson,et al.  The Role of Decision Support System (DSS) in Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis , 2012, PloS one.

[155]  M. Woodward,et al.  Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. , 2012, Diabetes research and clinical practice.

[156]  E. Staal,et al.  Hypertension in Aortic Stenosis: Implications for Left Ventricular Structure and Cardiovascular Events , 2012, Hypertension.

[157]  J. Selby,et al.  Improving Blood Pressure Control Through a Clinical Pharmacist Outreach Program in Patients With Diabetes Mellitus in 2 High-Performing Health Systems: The Adherence and Intensification of Medications Cluster Randomized, Controlled Pragmatic Trial , 2012, Circulation.

[158]  K. Eagle,et al.  Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). , 2012, The American journal of cardiology.

[159]  D. Sessler,et al.  Angiotensin Converting Enzyme Inhibitors Are Not Associated with Respiratory Complications or Mortality After Noncardiac Surgery , 2012, Anesthesia and analgesia.

[160]  Avis J. Thomas,et al.  Lifetime risks of cardiovascular disease. , 2012, The New England journal of medicine.

[161]  J. Saver,et al.  Renin–Angiotensin System Modulators Modestly Reduce Vascular Risk in Persons With Prior Stroke , 2012, Stroke.

[162]  G. Koren,et al.  The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers , 2011, Obstetrics and gynecology international.

[163]  S. Yusuf,et al.  Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). , 2012, Journal of the American College of Cardiology.

[164]  F. Messerli,et al.  Drug-induced hypertension: an unappreciated cause of secondary hypertension. , 2012, The American journal of medicine.

[165]  G. Jürgens,et al.  Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). , 2012, American journal of hypertension.

[166]  B. Sherrill,et al.  Single‐Pill vs Free‐Equivalent Combination Therapies for Hypertension: A Meta‐Analysis of Health Care Costs and Adherence , 2011, Journal of clinical hypertension.

[167]  Mike Kirby,et al.  Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology ( ESC ) , 2011 .

[168]  John Spertus,et al.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.

[169]  Christoph U. Lehmann,et al.  ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 2011, Pediatrics.

[170]  T. Douglas Bradley,et al.  Obstructive Sleep Apnea: The Most Common Secondary Cause of Hypertension Associated With Resistant Hypertension , 2011, Hypertension.

[171]  B. Ovbiagele,et al.  Presence of baseline prehypertension and risk of incident stroke , 2011, Neurology.

[172]  F. Rodríguez‐Artalejo,et al.  The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. , 2011, The American journal of clinical nutrition.

[173]  Stephen D. Persell,et al.  ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Impr , 2011, Circulation.

[174]  Valerie Smith,et al.  Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. , 2011, Archives of internal medicine.

[175]  P. Stewart,et al.  Inherited forms of mineralocorticoid hypertension , 2011, Current opinion in endocrinology, diabetes, and obesity.

[176]  A. Kessels,et al.  Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis , 2011, Blood pressure monitoring.

[177]  G. Howard,et al.  Ethnic Differences in Hypertension Incidence Among Middle-Aged and Older Adults: The Multi-Ethnic Study of Atherosclerosis , 2011, Hypertension.

[178]  Alan S. Brown,et al.  ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2011, Circulation.

[179]  E. Ford.  Trends in Mortality From All Causes and Cardiovascular Disease Among Hypertensive and Nonhypertensive Adults in the United States , 2011, Circulation.

[180]  Amy Earley,et al.  Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier , 2011, Annals of Internal Medicine.

[181]  Faha,et al.  Aha Guideline Effectiveness-based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update a Guideline from the American Heart Association Executive Writing Committee Expert Panel Members Cvd Risk Assessment Table 1. Class Iii Interventions (not Useful/effective and May Be Harmfu , 2022 .

[182]  K. Reynolds,et al.  Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension: A Meta-Analysis , 2012 .

[183]  M. Caulfield,et al.  Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial−Blood Pressure Lowering Arm (ASCOT-BPLA) , 2011, Journal of hypertension.

[184]  D. Jatužis,et al.  The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial , 2011, The Lancet.

[185]  Seemant Chaturvedi,et al.  Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[186]  M. Woodward,et al.  The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials , 2011, Journal of hypertension.

[187]  R. Light,et al.  Role of Home Blood Pressure Monitoring in Overcoming Therapeutic Inertia and Improving Hypertension Control: A Systematic Review and Meta-Analysis , 2011, Hypertension.

[188]  F. Cuccurullo,et al.  Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. , 2011, American journal of hypertension.

[189]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.

[190]  M. Woodward,et al.  Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. , 2010, European heart journal.

[191]  A. Viera,et al.  Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. , 2010, American journal of hypertension.

[192]  G. Liguori,et al.  Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006 , 2010, Diabetes Care.

[193]  A. Wallace,et al.  Association of the Pattern of Use of Perioperative &bgr;-Blockade and Postoperative Mortality , 2010, Anesthesiology.

[194]  P. Lloberes,et al.  Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial , 2010, Journal of hypertension.

[195]  Rod S Taylor,et al.  Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[196]  J. Orloff,et al.  Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives , 2010, Current medical research and opinion.

[197]  B. Brenner,et al.  Comparison of different measures of urinary protein excretion for prediction of renal events. , 2010, Journal of the American Society of Nephrology : JASN.

[198]  C. Bulpitt,et al.  Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial , 2010, The Lancet Neurology.

[199]  D. Mozaffarian,et al.  Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults A Scientific Statement From the American Heart Association Endorsed by the Preventive Cardiovascular Nurses Association and the Society of Behavioral Medicine , 2010 .

[200]  Devin M Mann,et al.  Comparison of the Framingham Heart Study Hypertension Model With Blood Pressure Alone in the Prediction of Risk of Hypertension: The Multi-Ethnic Study of Atherosclerosis , 2010, Hypertension.

[201]  Li-sheng Liu,et al.  Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial , 2010, Journal of hypertension.

[202]  M. Woodward,et al.  Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial , 2010, Hypertension.

[203]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[204]  T. Brennan,et al.  Disease management to promote blood pressure control among African Americans. , 2010, Population health management.

[205]  J. Montserrat,et al.  Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. , 2010, American journal of respiratory and critical care medicine.

[206]  Tom Fahey,et al.  Interventions used to improve control of blood pressure in patients with hypertension. , 2010, The Cochrane database of systematic reviews.

[207]  N. Poulter,et al.  Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis , 2010, Hypertension.

[208]  S. Denardo,et al.  Outcomes Among Hypertensive Patients With Concomitant Peripheral and Coronary Artery Disease: Findings From the INternational VErapamil-SR/Trandolapril STudy , 2010, Hypertension.

[209]  W. J. Elliott,et al.  Two Self-management Interventions to Improve Hypertension Control: A Randomized Trial , 2010 .

[210]  Souvik Sen,et al.  2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Circulation.

[211]  P. Lin,et al.  Hypertension Improvement Project: Randomized Trial of Quality Improvement for Physicians and Lifestyle Modification for Patients , 2009, Hypertension.

[212]  Li-sheng Liu,et al.  Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature , 2009, Hypertension Research.

[213]  Shimin Zheng,et al.  The potency of team-based care interventions for hypertension: a meta-analysis. , 2009, Archives of internal medicine.

[214]  S. Lakhan,et al.  Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis , 2009, International archives of medicine.

[215]  R. Peters,et al.  A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure. , 2009, The Netherlands journal of medicine.

[216]  G. Mancia,et al.  Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. , 2009, Journal of hypertension.

[217]  M. Kaste,et al.  Relationship of Blood Pressure, Antihypertensive Therapy, and Outcome in Ischemic Stroke Treated With Intravenous Thrombolysis: Retrospective Analysis From Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR) , 2009, Stroke.

[218]  A. Cohen-Solal,et al.  Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). , 2009, Journal of the American College of Cardiology.

[219]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[220]  G. Lip,et al.  Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. , 2009, European heart journal.

[221]  D. Mozaffarian,et al.  The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors , 2009, PLoS medicine.

[222]  D. Wald,et al.  Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials , 2010 .

[223]  D. Levy,et al.  Single Versus Combined Blood Pressure Components and Risk for Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.

[224]  M. Onuigbo.  ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. , 2009, Archives of internal medicine.

[225]  Susan Anderson,et al.  Irbesartan in patients with heart failure and preserved ejection fraction. , 2008, The New England journal of medicine.

[226]  M. Woodward,et al.  Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. , 2008, European heart journal.

[227]  D. de Zeeuw,et al.  Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. , 2008, American journal of epidemiology.

[228]  P. Miller,et al.  Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. , 2008, Addiction.

[229]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[230]  W. Young,et al.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[231]  C. Bulpitt,et al.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.

[232]  David Goff,et al.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. , 2008, Hypertension.

[233]  Furman S. McDonald,et al.  Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. , 2008, Journal of hospital medicine.

[234]  J. Ralston,et al.  Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. , 2008, JAMA.

[235]  Daniel W. Jones,et al.  A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research , 2008 .

[236]  Denis Xavier,et al.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.

[237]  B Neal,et al.  Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials , 2008, BMJ : British Medical Journal.

[238]  E. Ofili,et al.  Hypertension in Women: Part I , 2008, Journal of clinical hypertension.

[239]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[240]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[241]  E. Brown,et al.  The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. , 2008, Clinical therapeutics.

[242]  B. Davis,et al.  Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2008, Archives of internal medicine.

[243]  D. Levy,et al.  A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study , 2008, Annals of Internal Medicine.

[244]  Barry J. Davis,et al.  Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension , 2007, Diabetes Care.

[245]  P. Bath,et al.  Interventions for Deliberately Altering Blood Pressure in Acute Stroke , 2014, The Cochrane database of systematic reviews.

[246]  R. Fagard,et al.  Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis , 2007, Journal of hypertension.

[247]  S. Bangalore,et al.  Fixed-dose combinations improve medication compliance: a meta-analysis. , 2007, The American journal of medicine.

[248]  M. Mori,et al.  Association of ambulatory use of statins and beta-blockers with long-term mortality after vascular surgery. , 2007, Journal of hospital medicine.

[249]  J. Cutler,et al.  Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. , 2007, The American journal of cardiology.

[250]  P. Greenland,et al.  Predictive Utility of Pulse Pressure and Other Blood Pressure Measures for Cardiovascular Outcomes , 2007, Hypertension.

[251]  R. Schmieder,et al.  Renin-angiotensin system and cardiovascular risk , 2007, The Lancet.

[252]  P. Whelton,et al.  Association between the metabolic syndrome and chronic kidney disease in Chinese adults. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[253]  J. Newcomer,et al.  Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. , 2007, The Journal of clinical psychiatry.

[254]  Jeroen J. Bax,et al.  Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[255]  J. Laragh,et al.  Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial , 2006, Journal of hypertension.

[256]  Satoko Nakamura,et al.  Masked hypertension and target organ damage in treated hypertensive patients. , 2006, American journal of hypertension.

[257]  B. Davis,et al.  Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial , 2006, Hypertension.

[258]  Vandana Sundaram,et al.  Quality Improvement Strategies for Hypertension Management: A Systematic Review , 2006, Medical care.

[259]  M. Woodward,et al.  Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial , 2006, Journal of hypertension.

[260]  S. Oparil,et al.  Feasibility of treating prehypertension with an angiotensin-receptor blocker. , 2006, The New England journal of medicine.

[261]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[262]  Bryan Williams,et al.  Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials , 2006, Journal of hypertension.

[263]  A. Evangelista,et al.  Long-term vasodilator therapy in patients with severe aortic regurgitation. , 2005, The New England journal of medicine.

[264]  Yutaka Imai,et al.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. , 2005, Journal of the American College of Cardiology.

[265]  P. Lindenauer,et al.  Perioperative beta-blocker therapy and mortality after major noncardiac surgery. , 2005, The New England journal of medicine.

[266]  D. Lloyd‐Jones,et al.  Hypertension in adults across the age spectrum: current outcomes and control in the community. , 2005, JAMA.

[267]  T. Greene,et al.  Blood Pressure Control, Drug Therapy, and Kidney Disease , 2005, Hypertension.

[268]  Neil Chapman,et al.  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. , 2005, Archives of internal medicine.

[269]  D. E. Mathis,et al.  Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2005, Archives of internal medicine.

[270]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[271]  F. Gueyffier,et al.  Treatment of High Blood Pressure and Gain in Event-Free Life Expectancy , 2005, Vascular health and risk management.

[272]  François Gueyffier,et al.  Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome , 2005, Hypertension.

[273]  Barry R. Davis,et al.  Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril , 2005 .

[274]  I. Kantola,et al.  Bell or diaphragm in the measurement of blood pressure? , 2005, Journal of hypertension.

[275]  G. Remuzzi,et al.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial , 2005, The Lancet.

[276]  Daniel W. Jones,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.

[277]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[278]  Alan C. Wilson,et al.  Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. , 2005, The American journal of cardiology.

[279]  Harold,et al.  Effects of Treatment on Morbidity in Hypertension , 2005 .

[280]  C. Nelson-Piercy,et al.  Management of hypertension before, during, and after pregnancy , 2004, Heart.

[281]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[282]  T. Fahey,et al.  How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. , 2004, Archives of internal medicine.

[283]  R Alagesan,et al.  Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). , 2004, American heart journal.

[284]  J. Sear,et al.  Hypertension, hypertensive heart disease and perioperative cardiac risk. , 2004, British journal of anaesthesia.

[285]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[286]  S. Yusuf,et al.  Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease , 2004 .

[287]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[288]  Diederick E. Grobbee,et al.  Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.

[289]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[290]  K. Fox,et al.  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.

[291]  T. Fahey,et al.  The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis , 2003, Journal of hypertension.

[292]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[293]  L. Wilkins.  Diuretic Versus &agr;-Blocker as First-Step Antihypertensive Therapy: Final Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2003 .

[294]  D. Grobbee,et al.  Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials , 2003, Journal of Human Hypertension.

[295]  Thomas Lumley,et al.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.

[296]  Neil Chapman,et al.  Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. , 2003, Archives of internal medicine.

[297]  A. Hofman,et al.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.

[298]  Victor J Stevens,et al.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. , 2003, JAMA.

[299]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[300]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[301]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[302]  D. Bennett,et al.  Blood pressure and coronary heart disease: a review of the evidence. , 2002, Seminars in vascular medicine.

[303]  B. Davis,et al.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). , 2002, Journal of clinical hypertension.

[304]  Jan A Staessen,et al.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.

[305]  W. Young,et al.  Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. , 2002, Endocrinology and metabolism clinics of North America.

[306]  L. Fleisher.  Preoperative evaluation of the patient with hypertension. , 2002, JAMA.

[307]  T. Risler,et al.  Antihypertensive treatment for kidney transplant recipients , 2002 .

[308]  Jiang He,et al.  Effect of Aerobic Exercise on Blood Pressure , 2002, Annals of Internal Medicine.

[309]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[310]  L. Guize,et al.  Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. , 2002, Archives of internal medicine.

[311]  Sudha Seshadri,et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.

[312]  Antonio Addis,et al.  Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. , 2002, Clinical therapeutics.

[313]  Jiang He,et al.  Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2001, Hypertension.

[314]  L. Ruilope,et al.  A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease , 2001, Journal of hypertension.

[315]  D. Johnston.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack , 2001, The Lancet.

[316]  J. Cramer,et al.  A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.

[317]  B. Seifert,et al.  Chronic β-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection , 2001 .

[318]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .

[319]  S. Kimmel,et al.  Perioperative β-blocker withdrawal and mortality in vascular surgical patients , 2001 .

[320]  C. Mulrow,et al.  MANAGEMENT OF MILD CHRONIC HYPERTENSION DURING PREGNANCY: A REVIEW , 2000, Obstetrics and gynecology.

[321]  J. Manson,et al.  Systolic and Diastolic Blood Pressure, Pulse Pressure, and Mean Arterial Pressure as Predictors of Cardiovascular Disease Risk in Men , 2000, Hypertension.

[322]  P. Whelton,et al.  Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. , 2000, Hypertension.

[323]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[324]  Nick Freemantle,et al.  β Blockade after myocardial infarction: systematic review and meta regression analysis , 1999 .

[325]  R. D'Agostino,et al.  Clustering of metabolic factors and coronary heart disease. , 1999, Archives of internal medicine.

[326]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[327]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[328]  P. Whelton,et al.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.

[329]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[330]  W. Aronow,et al.  Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. , 1997, The American journal of cardiology.

[331]  P. Whelton,et al.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.

[332]  J. Cutler,et al.  Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.

[333]  G. Bray,et al.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.

[334]  N. Cook,et al.  Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. , 1997, The American journal of clinical nutrition.

[335]  A. Levey,et al.  Effect of Angiotensin-Converting Enzyme Inhibitors on the Progression of Nondiabetic Renal Disease , 1997, Annals of Internal Medicine.

[336]  R. Kloner,et al.  Sex- and age-related antihypertensive effects of amlodipine , 1996 .

[337]  C. Lewis,et al.  Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study. , 1996, Archives of internal medicine.

[338]  G. Boysen,et al.  Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study. , 1995, American journal of epidemiology.

[339]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[340]  V. Nicaud,et al.  Improving hypertension control among excessive alcohol drinkers: a randomised controlled trial in France. The WALPA Group. , 1995, Journal of epidemiology and community health.

[341]  Pats,et al.  Post-stroke antihypertensive treatment study. A preliminary result. , 1995, Chinese medical journal.

[342]  W. Applegate,et al.  Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. , 1994, Archives of internal medicine.

[343]  S. Rahimtoola,et al.  Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. , 1994, The New England journal of medicine.

[344]  S. Redline,et al.  Assessment of the validity and utility of a sleep-symptom questionnaire. , 1994, American journal of respiratory and critical care medicine.

[345]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[346]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[347]  J. Neaton,et al.  Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. , 1993, Archives of internal medicine.

[348]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[349]  N. Cook,et al.  The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I , 1992 .

[350]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[351]  S. Nattel,et al.  Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. , 1991, Circulation.

[352]  A. Haines,et al.  Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. , 1988, BMJ.

[353]  L. Kuller,et al.  Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. , 1988, Circulation.

[354]  J. Laragh,et al.  How common is white coat hypertension? , 1988, JAMA.

[355]  R. Newson,et al.  Beta adrenoceptor blockade is associated with increased survival in male but not female hypertensive patients: a report from the DHSS Hypertension Care Computing Project (DHCCP). , 1986, Journal of human hypertension.

[356]  R. Anderson,et al.  Withdrawal syndromes and the cessation of antihypertensive therapy. , 1981, Archives of internal medicine.

[357]  R. Bonow,et al.  Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. , 1981, The American journal of cardiology.

[358]  Iqbal Krishan,et al.  Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. , 1977, JAMA.

[359]  L. Wilhelmsen,et al.  Prevalence of primary and secondary hypertension: studies in a random population sample. , 1976, British medical journal.